A LOW BASELINE BLOOD NEUTROPHIL COUNT AND A HIGH PERCENTAGE OF TREG AMONG LEUCOCYTES ARE ASSOCIATED WITH AN INCREASED OVERALL SURVIVAL OF RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH BEVACIZUMAB
Résumé
Conference: 12th Meeting of the European-Association-of-Neuro-Oncology Location: GERMANY Date: OCT 12-16, 2016 - Meeting Abstract: P06.13